Privi Speciality Chemicals Limited — PPTs, 05-05-2025: Investor Presentation

1. Financial Highlights:

Privi Speciality Chemicals posted record revenue of Rs 628.37 Cr in Q4 and Rs 2,121.84 Cr for FY25, up 28% and 19% YoY respectively. EBITDA margins expanded to 23.46% (Q4) and 22.35% (FY25) on strong operating leverage. PAT doubled in Q4 to Rs 63.98 Cr and nearly doubled annually to Rs 184.75 Cr. Total assets increased to Rs 2,790.51 Cr from Rs 2,342.55 Cr, fueled by investments in property, plant & equipment and working capital. Net debt remained moderate at Rs 1,122.69 Cr with gearing below 1.1x.

2. Strategic Initiatives & Growth Drivers:

The PRIGIV plant (JV with Givaudan SA) was a key growth contributor. Capacity expansion by 6,000 MTPA through debottlenecking is underway, targeting completion by FY26 end, backed by Rs 250-300 Cr capex funded internally and via debt. New product launches including Indomerane, Floravone, Amber Woody Xtreme are scaling, with two more under production scale-up expected by FY27. Continued R&D and backward integration through proprietary CST and GTO technologies drive innovation and cost competitiveness.

3. Business Developments:

Enhanced JV partnership with Givaudan strengthens global fragrance leadership. Expanded aroma chemical portfolio targets fine fragrances, personal and home care segments. Backward integration stabilizes raw material supply and protects margins. Operations span seven manufacturing units and two R&D centers, supporting scale and innovation.

4. Market Position & Competitive Advantage:

Privi is a leader in aroma chemicals, particularly pine chemistry products like DHMOL, Amber fleur, Terpineol, and Pine oil. It supplies over 15 leading global fragrance and FMCG companies, with ~70% export mix. Proprietary CST and GTO technologies and backward integration ensure pricing power and supply security, establishing a solid competitive moat.

5. Investor Implications:

Strong margin gains, capacity ramp-up, and ongoing new product launches underpin positive growth potential. The established export base and strategic collaborations lessen market risks. Moderate leverage combined with asset growth indicates sound financial management. Privi stands out as a promising speciality chemicals stock with upside from execution of expansion and innovation initiatives.